Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
mattiafalchetto.osti@uniroma1.it
Mattia Falchetto Osti
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE MEDICO-CHIRURGICHE E DI MEDICINA TRASLAZIONALE
E-mail:
mattiafalchetto.osti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Moderate Hypofractionation in Patients with Low-risk Prostate Cancer: Long-term Outcomes
ANTICANCER RESEARCH
2018
30 Gy single dose stereotactic body radiation therapy (SBRT). Report on outcome in a large series of patients with lung oligometastatic disease
LUNG CANCER
2018
Single nucleotide polymorphism of gstp1 and pathological complete response in locally advanced rectal cancer patients treated with neoadjuvant concomitant radiochemotherapy
RADIATION ONCOLOGY JOURNAL
2018
Re-irradiation in lung disease by SBRT. A retrospective, single institutional study
RADIATION ONCOLOGY
2018
Oligoprogression during Abiraterone therapy treated with radiotherapy in mCRPC patients.
RADIOTHERAPY AND ONCOLOGY
2018
Two cases of capecitabine-induced ileitis in patients treated with radiochemotherapy to the pelvis and review of the literature
JOURNAL OF GASTROINTESTINAL CANCER
2018
Critical decision-making in radiotherapy for early stage breast cancer in a neo-adjuvant treatment era
EXPERT REVIEW OF ANTICANCER THERAPY
2017
Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy. results from a monoinstitutional cohort analysis of long-term survivors
HEMATOLOGICAL ONCOLOGY
2017
Mono-and Bi-weekly hypofractionated radiation therapy for the treatment of epithelial skin cancer in very elderly patients
ANTICANCER RESEARCH
2017
Preoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with Capecitabine in locally advanced rectal cancer. Short-term results of a multicentric study
RADIATION ONCOLOGY
2017
Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases
JOURNAL OF NEURO-ONCOLOGY
2017
The role of stereotactic body radiation therapy in oligometastatic colorectal cancer
MEDICINE
2017
Lung metastases treated with stereotactic ablative radiation therapy in oligometastatic colorectal cancer patients. outcomes and prognostic factors after long-term follow-up
CLINICAL COLORECTAL CANCER
2017
Radiation therapy for older patients with brain tumors
RADIATION ONCOLOGY
2017
Stereotactic body radiation therapy in primary and metastatic liver disease
ANTICANCER RESEARCH
2017
Repeated stereotactic radiosurgery for patients with progressive brain metastases
JOURNAL OF NEURO-ONCOLOGY
2016
Renin-angiotensin system inhibitors might help to reduce the development of symptomatic radiation pneumonitis after stereotactic body radiotherapy for lung cancer
CLINICAL LUNG CANCER
2016
Target delineation and optimal radiosurgical dose for pituitary tumors
RADIATION ONCOLOGY
2016
Single-fraction versus multifraction (3 × 9 gy) stereotactic radiosurgery for large (>2 cm) brain metastases: A comparative analysis of local control and risk of radiation-induced brain necrosis
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2016
Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy
ABDOMINAL RADIOLOGY
2016
« prima
< precedente
1
2
3
4
seguente ›
ultima »
Progetti di Ricerca
La radioterapia stereotassica frazionata extracranica e le terapie biologiche nel trattamento delle neoplasie solide metastatiche: analisi del controllo locale e della tossicità nei trattamenti combinati.
VALUTAZIONE DI FATTORI PROGNOSTICI CLINICO-PATOLOGICI IN PAZIENTI CON ADENOCARCINOMA DELLA PROSTATA A RISCHIO INTERMEDIO ED ALTO TRATTATI CON RADIOTERAPIA CURATIVA IPOFRAZIONATA ASSOCIATA AD ORMONOTERAPIA
Radioterapia stereotassica frazionata concomitante a immunoterapia o target-therapy nel trattamento delle metastasi cerebrali.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma